BASF and China-based Anhui Huaheng Biotechnology (AHB) have signed a Letter of Intent to confirm the feasibility of a joint operation for amino acid L-alanine production.
BASF has successfully qualified AHB’s L-alanine for industrial use.
The joint operation will be based on proprietary technology developed and already operated by AHB.
The product from the joint operation will serve BASF’s demand and for AHB to serve the pharmaceutical, fine chemical, food and beverage industries.
